9th Annual Pharma Pricing, Reimbursement & Market Access 2025

9th Annual Pharma Pricing, Reimbursement & Market Access 2025

7th, 8th & 9th October, 2025, Philadelphia, United States

This Pharma Pricing, Reimbursement & Market Access Conference brings together global stakeholders—including industry leaders, payers, HTA bodies, regulators, physicians, and patient advocates—to explore the latest challenges, opportunities, and innovations shaping access to medicines.

Please contact Kavitha at E-mail - a2F2aXRoYSB8IHZpcnR1ZWluc2lnaHQgISBjbyAhIGlu or call +44 20 3509 3779

DELEGATE REGISTRATION:

Super Early Bird (Valid Till 17th August)

Conference + Workshop

$999 (01 Delegate)

@ $1998 Group Discount (3 Delegates for the price of 2)

Conference Only

$899 (01 Delegate)

$1798 Group Discount (3 Delegates for the price of 2)

Standard Price

Conference + Workshop

$1499 (01 Delegate)

$2998 Group Discount (3 Delegates for the price of 2)

Conference Only

$1299 (01 Delegate)

$2598 Group Discount (3 Delegates for the price of 2)

SPONSORS:

Gold Sponsor - AccessSync

We have sponsorship opportunities available for the event, which gives you an opportunity to speak/exhibit, and create brand awareness. Here you can have a dedicated networking time, meet the leading international vendors and expand your knowledge of the latest business models. Please email to a2F2aXRoYSB8IHZpcnR1ZWluc2lnaHQgISBjbyAhIGlu for more details.

KEY SPEAKERS:

· RODNEY EMERSON, Vice President, Pricing & Contracts, Sandoz

· TOM CROCE, VP Global Patient Advocacy, Jazz Pharmaceuticals

· BOXIONG TANG, Former AVP Head of HEOR & Medical Value Access, Agenus

· GREG APOSTOL, VP & Head of Market Access, Alkermes

· KAELYN BUCK, Senior Director, Government Pricing & Contract Operations, Regeneron Pharmaceuticals

· SHANTHY KRISHNARAJAH, Sr. Director, New Products, Patient, Engagement Research Council & IRA, Johnson & Johnson

· DIEGO CORTINA DE LA FUENTE, Director, Value & Access - Global Value, Evidence Strategy, Biogen

· SANKET SHAH, Director, Global Value & HEOR, Jazz Pharmaceuticals

· CHAKITA WILLIAMS, Market Access, Pricing, Value Demonstration Strategy and Operations Director, Bristol Myers Squibb

· OMAR ALI, Head of Payers, Verpora (Former Government Payer, Nice HTA)

· EDWARD MCADAM, Director, Government Pricing, Contracting Operations and Analytics, Indivior

· DRAKE REITER, Director of Ph*rm*cy Operations, Priority Health

· ROSS MARGULIES, Partner & Attorney, Manatt Health

· ANKA G. EHRHARDT, Director, Cell-Based Assays / Analytical Research & Development, Merck

· HEMANTH KANAKAMEDALA, VP, Decision Science & RWE, Recursion

· RAHUL SHENOLIKAR, Lung Cancer Lead, Oncology Outcomes Research, AstraZeneca

· SWAMINATHAN SUBRAMANIAN, Head, US Global Pricing & Contracting, Regeneron Pharmaceuticals

· JAMIE GROSSMAN, National Account Director, HEOR, Bayer

· JOAQUIN F. MOULD, Global HEOR & Value Strategy Director, CSL Seqirus

· DINAKARAN BALASUBRAMANIAN, Head, Commercial Strategy & Insights, Biologics, Dr. Reddy’s Laboratories

· STEPHEN FRAMIL, Corporate Global Head of Accessibility, Merck

· RAHUL MITTAL, Head Strategy & Innovation – North, America, Dr. Reddy’s Laboratories

· IPEK OZER STILLMAN, Head, Global Health Economics, Payer, Value & Patient Access, Takeda

· MICHAEL CIARAMETARO, Managing Director, Avalere Health

· AMADEO SALVADOR, Senior Data Scientist, Abbvie

· PETER BARSCHDORFF, Vice President, Deallus

· CHERYL ROCHE ALEXANDER, Account Experience Specialist, UCB

· USMAN IQBAL, Chief Medical Officer, Julz Pharma

· HEATHER LEIGH FLANNERY, CEO & Co-Founder, AI MINDSystems Foundation

· KELLIE MURPHY, Senior Director, Head of Commercial, Capricor Therapeutics

· AYESHA AZAM, Associate Principal, Avalere Health

Plus more joining soon

KEY TOPICS & DISCUSSIONS:

· Value-Based Access Models

· IRA and State-level Pricing Initiatives

· Real-World Evidence (RWE) & Data-Driven Decisions

· HTA Evolution & Global Alignment

· Regulatory Landscape & Policy Updates

· International Pricing System

· Patient-Centric Market Access

· Digital Health & Technology Impact

· Affordability & Equity in Access

· Pricing Transparency & Sustainability

· Early Access, Accelerated Pathways

· Payer Engagement & Negotiation Strategies

· Cross-Functional Collaboration

· Innovative Contracting & Managed Entry Agreements

· Global vs Local Access Strategy

· Working Together – Stakeholders / Industry / Payers / Physicians /Patients

WHO SHOULD ATTEND:

Senior Vice Presidents, Vice Presidents, Senior Executives, Global Heads, Heads, Directors Senior Managers, Managers of:

Pricing, Reimbursement, Market Access, Commercial Pricing, Pricing Strategists, Health Economics, Regulatory Affairs, Governmental Affairs, Public Affairs, Public Policy Directors, Operations, Governmental bodies

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

Also check out other Business events in Riverhead, Health & Wellness events in Riverhead, Conferences in Riverhead.